A detailed history of Great West Life Assurance CO transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 20,073 shares of AGIO stock, worth $710,985. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,073
Previous 24,775 18.98%
Holding current value
$710,985
Previous $1.07 Million 16.56%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$41.19 - $49.72 $193,675 - $233,783
-4,702 Reduced 18.98%
20,073 $892,000
Q2 2024

Aug 12, 2024

SELL
$27.55 - $48.83 $175,465 - $310,998
-6,369 Reduced 20.45%
24,775 $1.07 Million
Q1 2024

May 13, 2024

BUY
$21.32 - $34.81 $11,512 - $18,797
540 Added 1.76%
31,144 $911,000
Q4 2023

Feb 13, 2024

BUY
$19.97 - $24.53 $54,737 - $67,236
2,741 Added 9.84%
30,604 $677,000
Q3 2023

Nov 14, 2023

SELL
$24.36 - $28.18 $11,400 - $13,188
-468 Reduced 1.65%
27,863 $689,000
Q2 2023

Aug 10, 2023

BUY
$21.38 - $29.19 $60,890 - $83,133
2,848 Added 11.18%
28,331 $807,000
Q1 2023

May 12, 2023

BUY
$21.74 - $30.93 $11,957 - $17,011
550 Added 2.21%
25,483 $586,000
Q4 2022

Feb 10, 2023

BUY
$24.81 - $31.52 $339,276 - $431,036
13,675 Added 121.47%
24,933 $703,000
Q3 2022

Nov 01, 2022

BUY
$19.51 - $34.14 $219,643 - $384,348
11,258 New
11,258 $318,000
Q2 2022

Aug 09, 2022

BUY
$17.06 - $31.42 $2,576 - $4,744
151 Added 5.12%
3,101 $68,000
Q1 2022

May 12, 2022

BUY
$26.68 - $34.81 $3,761 - $4,908
141 Added 5.02%
2,950 $91,000
Q4 2021

Feb 14, 2022

SELL
$29.58 - $49.78 $13,488 - $22,699
-456 Reduced 13.97%
2,809 $92,000
Q3 2021

Nov 15, 2021

SELL
$41.92 - $58.18 $22,385 - $31,068
-534 Reduced 14.06%
3,265 $152,000
Q1 2021

May 17, 2021

SELL
$44.23 - $57.5 $5,705 - $7,417
-129 Reduced 3.28%
3,799 $194,000
Q3 2020

Nov 17, 2020

BUY
$33.87 - $55.93 $133,041 - $219,693
3,928 New
3,928 $137,000
Q3 2020

Nov 13, 2020

SELL
$33.87 - $55.93 $133,041 - $219,693
-3,928 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$30.08 - $50.59 $118,154 - $198,717
3,928 New
3,928 $187,000
Q3 2019

Oct 25, 2019

SELL
$32.4 - $49.58 $223,333 - $341,754
-6,893 Closed
0 $0
Q2 2019

Jul 31, 2019

SELL
$46.17 - $68.1 $36,566 - $53,935
-792 Reduced 10.31%
6,893 $0
Q1 2019

May 08, 2019

BUY
$45.92 - $67.67 $49,869 - $73,489
1,086 Added 16.46%
7,685 $517,000
Q4 2018

Feb 12, 2019

BUY
$42.73 - $76.53 $45,122 - $80,815
1,056 Added 19.05%
6,599 $294,000
Q3 2017

Nov 09, 2017

BUY
$54.89 - $67.12 $304,255 - $372,046
5,543
5,543 $359,000

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $1.94B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.